Tag
LSD
- Royal Ontario Museum runs psychedelics exhibit until December
- Athlete ran 500 miles on psychedelic drugs for upcoming documentary
- Definium Therapeutics soars on Phase 3 trial win with LSD depression drug
- Psychedelic Therapeutics & Drug Development Conference kicks off in New Orleans
- Experts contemplate national psychedelic therapy legalization at Harvard
- Sarpa salpa: the psychedelic fish you've probably never heard of
- University student discovers novel psychoactive fungus on flower
- Psychedelic Healing Shack goes up for sale, owner sick of conflict with Detroit officials
- Taking psilocybin or LSD can lessen frequency of severe headaches by 25%
- MindBio Therapeutics uses AI speech analysis to see if you've taken its LSD drug
- Psychedelic YouTuber Willy Myco drops world's first LSD synthesizing tutorial vid
- Psychedelic drug developer MindMed set for listing on Nasdaq Biotechnology Index
- MAPS partners with diverse artist lineup for psychedelic music & education initiative
- Denver prepares to host psychedelic therapy expo in November
- Kingston psychedelics complex celebrates grand opening
- Psychedelic drugs for therapy: history, effectiveness, legal status
- Can psychedelics help with chronic pain?
- U.S. invests millions in psychedelics research to treat chronic pain in older adults
- Controversial figure Dana Larsen gets his psychedelics business license back
- Microdosing LSD shows potential antidepressant effects in landmark study
- Psychedelic drug industry collaborations increased by 500% since 2019
- Vancouver police raid Medicinal Mushroom Dispensary locations, owner arrested
- Psychedelics may help athletes' mental health: UoT professor
- Microdosing LSD could help you sleep better: MindBio Therapeutics
- MindBio Therapeutics receives approval for LSD study for major depression
- NIH invests $1.5M in psychedelics research for substance use disorders
- LSD microdosing shows promise as treatment for major depression: MindBio study
- International psychedelics market to reach US$8.3B by 2027: ReportLinker
- LSD helps alleviate anxiety and major depression symptoms: MindMed
- PsyCan aims to be ‘go‑to’ psychedelics industry organization, receives support from lawmakers
- Psychedelic drugs market awaits nearly 100% revenue expansion by 2026 end: Fairfield
- Vancouver mushroom dispensaries continue to operate in legal grey area
- MindMed announces initial patient dosing in MM‑120 study
- Phillips Lytle announces the inception of its Psychedelic & Mental Health Therapies Practice
- Psychedelic therapeutics market to have steady growth: InsightAce
- U.S. psychedelic drug market to reach $8.9B by 2029: DBMR report
- Delic Labs granted permission to study psychedelics including LSD, MDMA
- Only difference between LSD and synthetic psilocybin experience is duration, researchers say
- Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M
- Consuming cannabis while on psychedelics makes the experience stronger, researchers say
- Positions of NIH, FDA signal we're 'on the brink of a psychedelic revolution'
- California Senate passes psychedelic decriminalization bill
- LSD could be used to treat people with autism, study suggests
- Nature amplifies therapeutic effects of psychedelics: study
- Proposed amendment could greatly expand access to psychedelic therapy in Canada
- Could microdosing psychedelics help treat schizophrenia?